Business Description
Captor Therapeutics SA
ISIN : PLCPTRT00014
Compare
Compare
Traded in other countries / regions
CTX.Poland60Q.Germany IPO Date
2021-04-19Description
Captor Therapeutics SA is a biopharmaceutical company. It is focused on development of protein degradation drugs for cancer and autoimmune diseases, which have limited or no known treatment options.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 8.9 | |||||
| Equity-to-Asset | 0.65 | |||||
| Debt-to-Equity | 0.13 | |||||
| Debt-to-EBITDA | -0.15 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 3.32 | |||||
| Beneish M-Score | -2.15 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -98 | |||||
| 3-Year EPS without NRI Growth Rate | -57.4 | |||||
| 3-Year FCF Growth Rate | -260 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 103.62 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 48.88 | |||||
| 9-Day RSI | 46.96 | |||||
| 14-Day RSI | 46.81 | |||||
| 6-1 Month Momentum % | 28.98 | |||||
| 12-1 Month Momentum % | -32.5 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.82 | |||||
| Quick Ratio | 2.82 | |||||
| Cash Ratio | 2.37 | |||||
| Days Sales Outstanding | 81.96 | |||||
| Days Payable | 307.9 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -12.6 | |||||
| Shareholder Yield % | -10.92 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 51.97 | |||||
| Operating Margin % | -255.81 | |||||
| Net Margin % | -250.46 | |||||
| FCF Margin % | -217.2 | |||||
| ROE % | -84.58 | |||||
| ROA % | -57.04 | |||||
| ROIC % | -183.1 | |||||
| 3-Year ROIIC % | 4211.65 | |||||
| ROC (Joel Greenblatt) % | -603.01 | |||||
| ROCE % | -81.32 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 11.94 | |||||
| PS Ratio | 20.67 | |||||
| PB Ratio | 6.96 | |||||
| Price-to-Tangible-Book | 7.15 | |||||
| EV-to-EBIT | -6.55 | |||||
| EV-to-EBITDA | -7.31 | |||||
| EV-to-Revenue | 16.32 | |||||
| EV-to-FCF | -7.31 | |||||
| Price-to-Net-Current-Asset-Value | 8.77 | |||||
| Price-to-Net-Cash | 11.95 | |||||
| Earnings Yield (Greenblatt) % | -15.27 | |||||
| FCF Yield % | -11.42 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Captor Therapeutics SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil zł) | 18.64 | ||
| EPS (TTM) (zł) | -9.04 | ||
| Beta | 0.53 | ||
| Volatility % | 49.31 | ||
| 14-Day RSI | 46.81 | ||
| 14-Day ATR (zł) | 2.706009 | ||
| 20-Day SMA (zł) | 76.72 | ||
| 12-1 Month Momentum % | -32.5 | ||
| 52-Week Range (zł) | 59 - 121 | ||
| Shares Outstanding (Mil) | 4.66 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Captor Therapeutics SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Captor Therapeutics SA Stock Events
| Event | Date | Price(zł) | ||
|---|---|---|---|---|
| No Event Data | ||||
Captor Therapeutics SA Frequently Asked Questions
What is Captor Therapeutics SA(WAR:CTX)'s stock price today?
The current price of WAR:CTX is zł76.00. The 52 week high of WAR:CTX is zł121.00 and 52 week low is zł59.00.
When is next earnings date of Captor Therapeutics SA(WAR:CTX)?
The next earnings date of Captor Therapeutics SA(WAR:CTX) is 2024-11-28.
Does Captor Therapeutics SA(WAR:CTX) pay dividends? If so, how much?
Captor Therapeutics SA(WAR:CTX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers